California will manufacture more affordable insulin in a partnership with nonprofit generic drugmaker Civica Rx, Gov. Gavin Newsom announced Saturday during a visit to Southern California. 

The partnership will provide insulin to Californians for $30 per 10 milliliters, the governor said during a stop at a Kaiser warehouse in Downey. The visit is part of a statewide tour to highlight policies — a road trip alternative to the governor’s traditional State of the State address. 

The 10-year partnership will be administered through Cal Rx. Manufacturing is expected to begin later this year with deliveries coming next year, Newsom said.

“This a big deal for us,” Newsom said.

As part of the $50 million contract, Civica will produce three insulins — glargine, lispro and aspart. They will be available in vials and pre-filled pens with the Cal Rx label. 

It was not immediately clear where the products will be manufactured.